PMC:7652766 / 95191-95507
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T466 | 0-316 | Sentence | denotes | Aiming at comparing the effects of favipiravir and lopinavir/ritonavir, Cai et al. (333) conducted an open, non-randomized, before-after controlled study with 80 patients and found that favipiravir favored viral clearance and improved chest CT, having caused fewer adverse effects than the lopinavir/ritonavir group. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3478 | 162-170 | Species | denotes | patients | Tax:9606 |
| 3481 | 35-46 | Chemical | denotes | favipiravir | MESH:C462182 |
| 3482 | 51-70 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3483 | 186-197 | Chemical | denotes | favipiravir | MESH:C462182 |
| 3484 | 290-309 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |